164 related articles for article (PubMed ID: 6373843)
1. Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine.
Sheidler VR; Ettinger DS; Diasio RB; Enterline JP; Brown MD
J Clin Pharmacol; 1984 Apr; 24(4):155-9. PubMed ID: 6373843
[TBL] [Abstract][Full Text] [Related]
2. Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis.
Stambaugh JE; McAdams J; Vreeland F
J Clin Pharmacol; 1984; 24(11-12):480-5. PubMed ID: 6392353
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy.
Cronin CM; Sallan SE; Gelber R; Lucas VS; Laszlo J
J Clin Pharmacol; 1981; 21(S1):43S-50S. PubMed ID: 7028793
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
[TBL] [Abstract][Full Text] [Related]
6. Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.
Heim ME; Queisser W; Altenburg HP
Cancer Chemother Pharmacol; 1984; 13(2):123-5. PubMed ID: 6467496
[TBL] [Abstract][Full Text] [Related]
7. Levonantradol for chemotherapy-induced emesis: phase I-II oral administration.
Laszlo J; Lucas VS; Hanson DC; Cronin CM; Sallan SE
J Clin Pharmacol; 1981; 21(S1):51S-56S. PubMed ID: 7298875
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of refractory cytostatic agent-induced vomiting with the synthetic cannabinoid levonantradol].
Heim ME; Queisser W
Onkologie; 1982 Apr; 5(2):94-6. PubMed ID: 7048169
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with levonantradol hydrochloride in the prevention of cancer chemotherapy-induced nausea and vomiting.
Heim ME; Romer W; Queisser W
J Clin Pharmacol; 1981; 21(S1):86S-89S. PubMed ID: 7298877
[TBL] [Abstract][Full Text] [Related]
10. Oral levonantradol in the treatment of chemotherapy-induced emesis: preliminary observations.
Diasio RB; Ettinger DS; Satterwhite BE
J Clin Pharmacol; 1981; 21(S1):81S-85S. PubMed ID: 7298876
[TBL] [Abstract][Full Text] [Related]
11. Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
Stuart-Harris RC; Mooney CA; Smith IE
Clin Oncol; 1983 Jun; 9(2):143-6. PubMed ID: 6309451
[TBL] [Abstract][Full Text] [Related]
12. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
[TBL] [Abstract][Full Text] [Related]
13. Levonantradol for the treatment of chemotherapy-induced nausea and vomiting.
Gerhartz HH; Binsack T; Hiller E
Klin Wochenschr; 1983 Jul; 61(14):719-21. PubMed ID: 6350696
[TBL] [Abstract][Full Text] [Related]
14. Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy.
Joss RA; Galeazzi RL; Bischoff A; Do DD; Goldhirsch A; Brunner KW
Cancer Chemother Pharmacol; 1982; 9(1):61-4. PubMed ID: 7139853
[TBL] [Abstract][Full Text] [Related]
15. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
Einhorn LH; Nagy C; Furnas B; Williams SD
J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
[TBL] [Abstract][Full Text] [Related]
16. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
Chan HS; Correia JA; MacLeod SM
Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479
[TBL] [Abstract][Full Text] [Related]
17. A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy.
Hutcheon AW; Palmer JB; Soukop M; Cunningham D; McArdle C; Welsh J; Stuart F; Sangster G; Kaye S; Charlton D
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1087-90. PubMed ID: 6352278
[TBL] [Abstract][Full Text] [Related]
18. Phase 1 trial of levonantradol in chemotherapy-induced emesis.
Tyson LB; Gralla RJ; Clark RA; Kris MG; Bordin LA; Bosl GJ
Am J Clin Oncol; 1985 Dec; 8(6):528-32. PubMed ID: 4083271
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
Tsukuura H; Miyazaki M; Morita T; Sugishita M; Kato H; Murasaki Y; Gyawali B; Kubo Y; Ando M; Kondo M; Yamada K; Hasegawa Y; Ando Y
Oncologist; 2018 Mar; 23(3):367-374. PubMed ID: 29038236
[TBL] [Abstract][Full Text] [Related]
20. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
Lane M; Smith FE; Sullivan RA; Plasse TF
Am J Clin Oncol; 1990 Dec; 13(6):480-4. PubMed ID: 2173391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]